3 Penny Stocks to Add to Your Watchlist in Late January
With the stock market taking a bearish turn for both penny stocks and blue chips over the past week, investors are working to understand what could happen in the near or distant future. Right now, we are witnessing several major companies report earnings with mixed results. While many of the top banks posted positive numbers, entertainment companies such as Netflix, posted less-than-stellar results.
This led to NFLX stock seeing its largest single-day drop since 2012. So, with this major volatility in the stock market, it all comes down to investors and their strategies to try and find the best penny stocks to buy. While it can be challenging to do so given the sheer amount of stocks out there and movement in general, making money with penny stocks is entirely possible in 2022.
Aside from all of this, we are still in the midst of the pandemic which means that we are likely to see momentum continue in both directions. So, with a close eye on what is going on in the world and a thorough understanding of how to trade penny stocks, navigating 2022 can be much easier. Considering this, let’s take a look at three penny stocks that exploded during trading today.
3 Penny Stocks That Exploded During Trading Today
- Bon Natural Life Ltd. (NASDAQ: BON)
- Vivos Therapeutics Inc. (NASDAQ: VVOS)
- BioDelivery Sciences International Inc. (NASDAQ: BDSI)
Bon Natural Life Ltd. (NASDAQ: BON)
With an 8% gain at midday, many investors are watching shares of BON stock right now. The main news for Bon Natural Life comes as the company announced an initial purchase order from Chongqing Fudoudou Technology Co. Ltd. for the former’s FeatherPure Women’s Personal Care Gel. While this was announced around a week ago, it is still having a significant effect on how BON stock trades.
“We are excited to officially kick off the partnership with FDD. This represents a unique opportunity for BON to gain enhanced access to FDD’s extensive retail consumer network. As adoption of women’s health awareness continues to rise, we expect women’s health expenditure will grow exponentially and FeatherPure will take the lead in the market.”The Chairman and CEO of Bon Natural Life, Richard Hu
This is great news for the company, and should help it to continue expanding into the women’s health market. If you’re not familiar, Bon Natural manufactures personal care products. This includes plant extracted fragrances, natural health supplements, bioactive food ingredients, and much more.
[Read More] 5 Household Name Penny Stocks To Buy Under $5
While it is hard to say what the long-term trajectory of BON stock will be, this announcement is exciting to keep in mind. And with its sizable gain today, BON stock could be worth adding to your list of penny stocks to watch.
Vivos Therapeutics Inc. (NASDAQ: VVOS)
One of the largest gainers of the day so far with high volume as well, is VVOS stock. By midday, shares of VVOS stock had shot up by over 12%, to almost $2.50 per share. The main news for Vivos comes as the company announced several increases in metrics for its SleepImage Home Sleep Apnea Tests. It stated that it had a 5.7 times increase in the number of BIPs administering home sleeping tests which is quite substantial.
“Converting positive OSA tests using our HSTs into Vivos System case starts is a major focus of our Practice Advisors and support personnel at Vivos as we roll into 2022. We also expect that our new pricing arrangement with SleepImage will yield positive financial results for Vivos.”The CEO and Chairman of Vivos, Kirk Huntsman
In the past five days, shares of VVOS stock have jumped by over 28% despite a one-year drop of almost 65%. While it is hard to say if VVOS stock can keep these gains up, there is no doubting the recent bullish turnaround we’ve seen. So, with that in mind, do you think that VVOS stock is worth adding to your penny stocks watchlist moving forward?
BioDelivery Sciences International Inc. (NASDAQ: BDSI)
Today, shares of BDSI stock jumped by over 5.5% to over $3.35 per share. This gives BDSI stock a give day gain of almost 10%. And while this may not seem like much, it is quite substantial given the rest of the market’s performance during that time.
While no major company-specific news was released today, it did announce new guidance for the full year 2021 results. The company stated that net product revenues should come out near the upper end of its previously guided range. This could be around $165 to $167 million. This would be a 6.1% increase YoY considering the mid-point of that range.
It’s worth noting that BDSI has three drugs currently approved by the FDA in its pipeline. This includes Belbuca, Symproic, and Elyxyb which are all used in different treatment purposes. However, the main source of revenue for the 2021 year seems to be Belbuca, with more than $147 million projected in net sales. All of these numbers are exciting and show positive growth with the company. Considering this, is BDSI stock worth buying or not?
Can Penny Stocks Continue to Make Gains?
When it comes to finding the best penny stocks to buy right now, there are plenty of options to choose from. While it can be challenging given the amount of movement in the stock market, having a strategy will be your best choice. Right now, this involves fully understanding what is causing either industries at large or companies specifically, to move. This could be industry-specific announcements, news related to Covid, and anything in between.
But, considering exactly how this will affect your portfolio is paramount to success. In addition, knowing what your investing goals are and how to take advantage of that. So, always think outside of the box and consider which companies could gain given the current market. Considering all of that, do you think that penny stocks can continue to make gains?
If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!